Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for acute mania in bipolar disorder
IRCT20090117001556N155Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of minocycline in bipolar disorder (BD) and mania (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Mania severity. Started Jan 2024; status: completed.
02
Drugs
minocycline
03
Conditions
bipolar disorder (BD)mania
Beyond the preview
Go deeper on IRCT20090117001556N155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N155.